share_log

基石藥業-B:臨時股東大會通告

CSTONE PHARMA-B: NOTICE OF EXTRAORDINARY GENERAL MEETING

香港交易所 ·  Dec 28, 2023 04:05
Summary by Moomoo AI
基石藥業-B將於2024年1月17日舉行臨時股東大會,地點為中國上海市浦東新區海陽西路555號前灘中心三樓會議中心B廳。會議將討論並投票決定是否批准向執行董事兼首席執行官楊建新博士授出的購股權,該購股權涉及以每股2.350港元的行使價認購合共14,000,000股股份。股東將通過投票方式決定此普通決議案,並可委任代表出席及投票。股份過戶登記將於2024年1月12日至17日暫停,以確定有資格出席大會及投票的股東名單。
基石藥業-B將於2024年1月17日舉行臨時股東大會,地點為中國上海市浦東新區海陽西路555號前灘中心三樓會議中心B廳。會議將討論並投票決定是否批准向執行董事兼首席執行官楊建新博士授出的購股權,該購股權涉及以每股2.350港元的行使價認購合共14,000,000股股份。股東將通過投票方式決定此普通決議案,並可委任代表出席及投票。股份過戶登記將於2024年1月12日至17日暫停,以確定有資格出席大會及投票的股東名單。
KEYSTONE PHARMACEUTICAL-B WILL BE HELD ON 17 JANUARY 2024 AT THE PROVISIONAL GENERAL MEETING ON 17 JANUARY 2024 IN HALL B, 3F CONFERENCE CENTRE, 555 HAIYANG WEST ROAD, PUDONG NEW DISTRICT, SHANGHAI, CHINA. The Meeting will discuss and vote on whether to approve the share option granted to the Executive Director and Chief Executive Officer, Dr. Jian Xian Yang, which involves the subscription of a total of 14,000,000 shares at an exercise price of HK$2,350 per share. Shareholders will decide on this ordinary resolution by voting and may appoint representatives to attend and vote. Share transfer registration will be suspended from 12 to 17 January 2024 to determine the list of shareholders who are eligible to attend the general meeting and vote.
KEYSTONE PHARMACEUTICAL-B WILL BE HELD ON 17 JANUARY 2024 AT THE PROVISIONAL GENERAL MEETING ON 17 JANUARY 2024 IN HALL B, 3F CONFERENCE CENTRE, 555 HAIYANG WEST ROAD, PUDONG NEW DISTRICT, SHANGHAI, CHINA. The Meeting will discuss and vote on whether to approve the share option granted to the Executive Director and Chief Executive Officer, Dr. Jian Xian Yang, which involves the subscription of a total of 14,000,000 shares at an exercise price of HK$2,350 per share. Shareholders will decide on this ordinary resolution by voting and may appoint representatives to attend and vote. Share transfer registration will be suspended from 12 to 17 January 2024 to determine the list of shareholders who are eligible to attend the general meeting and vote.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more